Drug Topics September 20, 2024
Brian Nowosielski

In its first move since the July interim report detailing pharmacy benefit manager practices, the FTC is now suing CVS Caremark, Express Scripts, and Optum Rx.

Just days after Cigna’s pharmacy benefit manager (PBM), Express Scripts, filed a lawsuit against the Federal Trade Commission (FTC) for defamation regarding the Commission’s July interim staff report, the FTC countered and filed a lawsuit against the “Big 3” PBMs— CVS Caremark, Express Scripts, and Optum Rx—for using unfair practices to inflate insulin prices.

“Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed,” said Rahul Rao, Deputy Director...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Pharma, Pharma / Biotech
Trump tariffs could drive up generic drug costs: 5 takeaways
Pharma Pulse 11/25/24: Deepening Patient Relationships,
BridgeBio poised to challenge Pfizer after Attruby approval
How Alto Pharmacy Is Redefining the Pharmacy Experience Through Digital Innovation
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article